Rossari Biotech Limited (NSE:ROSSARI)
459.95
+2.00 (0.44%)
Mar 10, 2026, 10:59 AM IST
Rossari Biotech Revenue
Rossari Biotech had revenue of 5.82B INR in the quarter ending December 31, 2025, with 13.45% growth. This brings the company's revenue in the last twelve months to 22.91B, up 16.09% year-over-year. In the fiscal year ending March 31, 2025, Rossari Biotech had annual revenue of 20.80B with 13.64% growth.
Revenue (ttm)
22.91B
Revenue Growth
+16.09%
P/S Ratio
1.11
Revenue / Employee
42.82M
Employees
535
Market Cap
25.36B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sirca Paints India | 4.59B |
| Fineotex Chemical | 5.78B |
| Tatva Chintan Pharma Chem | 4.80B |
| Savita Oil Technologies | 41.44B |
| Jubilant Agri and Consumer Products | 18.04B |
| NOCIL | 13.12B |
| Veedol Corporation | 20.94B |
| Laxmi Organic Industries | 28.21B |
Rossari Biotech News
- 7 weeks ago - Rossari Biotech Ltd (BOM:543213) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst ... - GuruFocus
- 7 weeks ago - Q3 2026 Rossari Biotech Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Rossari Biotech Ltd (BOM:543213) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 4 months ago - Q2 2026 Rossari Biotech Ltd Earnings Call Transcript - GuruFocus
- 1 year ago - Rossari Biotech’s subsidiary wins GST appeal; previous tax order set aside - Business Upturn
- 1 year ago - Rossari Biotech Ltd (BOM:543213) Q3 2025 Earnings Call Highlights: Strong Export Growth and ... - GuruFocus
- 1 year ago - Q3 2025 Rossari Biotech Ltd Earnings Call Transcript - GuruFocus
- 1 year ago - Rossari Biotech stock drops 4.28% following Q2 results - Business Upturn